FDA warns breast implants may be linked to additional cancers

with No Comments
The agency is not recommending all patients remove implants—instead, it’s warning patients and their healthcare providers to keep an eye out for any breast health changes.

 

(Tasmiha Khan/ Health) —  The U.S. Food and Drug Administration is warning patients who have breast implants or are considering getting them of additional cancers linked to implants, according to an FDA Safety Communication issued Thursday.

The cancers—squamous cell carcinoma (SCC) and various lymphomas—are considered extremely rare, but the agency is still urging patients and healthcare providers to be aware of the newly-discovered potential risks associated with breast implants.

The cancers are also different from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)—another rare type of cancer linked to breast implants with textured surfaces. In 2019, the FDA requested Allergan—the manufacturer of a specific type of textured implant—to recall the specific implants associated with an increased risk of BIA-ALCL. 9…)

read full story